Ghosh Nalini Kanta, R Rahul, Singh Ashish, Malage Somanath, Sharma Supriya, Kumar Ashok, Singh Rajneesh Kumar, Behari Anu, Kumar Ashok, Saxena Rajan
Department of Surgical Gastroenterology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.
Ann Hepatobiliary Pancreat Surg. 2023 Aug 31;27(3):258-263. doi: 10.14701/ahbps.22-130. Epub 2023 May 2.
BACKGROUNDS/AIMS: Hemangiomas are the most common benign liver lesions; however, they are usually asymptomatic and seldom require surgery. Enucleation and resection are the most commonly performed surgical procedures for symptomatic lesions. This study aims to compare the outcomes of these two surgical techniques.
A retrospective analysis of symptomatic hepatic hemangiomas (HH) operated upon between 2000 and 2021. Patients were categorized into the enucleation and resection groups. Demographic profile, intraoperative bleeding, and morbidity (Clavien-Dindo Grade) were compared. Independent t-test and chi-square tests were used for continuous and categorical variables respectively. p-value of < 0.05 was considered significant.
Sixteen symptomatic HH patients aged 30 to 66 years underwent surgery (enucleation = 8, resection = 8) and majority were females (n = 10 [62.5%]). Fifteen patients presented with abdominal pain, and one patient had an interval increase in the size of the lesion from 9 to 12 cm. The size of hemangiomas varied from 6 to 23 cm. The median blood loss (enucleation: 350 vs. resection: 600 mL), operative time (enucleation: 5.8 vs. resection: 7.5 hours), and postoperative hospital stay (enucleation: 6.5 vs. resection: 11 days) were greater in the resection group (statistically insignificant). In the resection group, morbidity was significantly higher (62.6% vs. 12.5%, = 0.05), including one mortality. All patients remained asymptomatic during the follow-up.
Enucleation was simpler with less morbidity as compared to resection in our series. However, considering the small number of patients, further studies are needed with comparable groups to confirm the superiority of enucleation over resection.
背景/目的:肝血管瘤是最常见的肝脏良性病变;然而,它们通常无症状,很少需要手术。剜除术和切除术是针对有症状病变最常施行的外科手术。本研究旨在比较这两种手术技术的疗效。
对2000年至2021年间接受手术的有症状肝血管瘤(HH)患者进行回顾性分析。患者被分为剜除术组和切除术组。比较人口统计学资料、术中出血情况和并发症(Clavien-Dindo分级)。连续变量和分类变量分别采用独立t检验和卡方检验。p值<0.05被认为具有统计学意义。
16例年龄在30至66岁的有症状HH患者接受了手术(剜除术=8例,切除术=8例),大多数为女性(n=10例[62.5%])。15例患者表现为腹痛,1例患者病变大小从9厘米增至12厘米。肝血管瘤大小从6厘米至23厘米不等。切除术组的术中失血量中位数(剜除术:350毫升 vs. 切除术:600毫升)、手术时间(剜除术:5.8小时 vs. 切除术:7.5小时)和术后住院时间(剜除术:6.5天 vs. 切除术:11天)均更长(无统计学意义)。切除术组的并发症发生率显著更高(62.6% vs. 12.5%,p=0.05),包括1例死亡。所有患者在随访期间均无症状。
在我们的系列研究中,与切除术相比,剜除术更简单,并发症更少。然而,考虑到患者数量较少,需要在可比组中进行进一步研究以证实剜除术优于切除术。